Analysis of the safety reporting requirements of drug clinical trial institutions in China
WU Da-wei
YU An-qi
YAN Zhao
CHEN Wen-na
GU Yue-long
HUANG Hui-yao
FANG Hong
WANG Hui
TANG Qi-yu
XU Zhen-gang
TANG Yu
LI Ning
Machine-generated Keywords:
Publication Date:2021-08-31
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:6( 1503-1508 )
